Larvol Delta - Aulos-Bioscience-Doses-First-Patient-in-Phase-2-Cohort-Evaluating-AU007-in-Combination-With-Nivolumab-for-SecondLine-Treatment-of-Melanoma

imneskibart (AU-007) - Aulos Biosci

https://www.businesswire.com/news/home/20250414240962/en/Aulos-Bioscience-Doses-First-Patient-in-Phase-2-Cohort-Evaluating-AU-007-in-Combination-With-Nivolumab-for-Second-Line-Treatment-of-Melanoma

Apr 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next